Spotlight
Clinical
Video Series
News
Partners
CME/CE
Subscribe
Significance of SRF vs IRF in nAMD
Experts discuss the management of subretinal fluid (SRF) and intraretinal fluid (IRF) in patients with neovascular age-related macular degeneration (nAMD).
EP: 1.Overview of Anti-VEGF Treatments for AMD and DME
EP: 2.Barriers to Optimal Treatment Outcomes
EP: 3.Patient and Cross-Care Education Strategies for AMD and DME
EP: 4.Real-World Long-Term Safety Data of Anti-VEGF Agents
EP: 5.Treat and Extend Strategy for Anti-VEGF Injections
EP: 6.Markers of Disease Progression in nAMD Patients
Now Viewing
EP: 7.Significance of SRF vs IRF in nAMD
EP: 8.Current Treatment Options for nAMD
Related Videos
Related Content
